This report highlights trends in Japan’s pharmaceutical market, notably how costly, long-listed products will be replaced due to generic and biosimilar industries continuing to grow in volume and market share. The report also discusses increased internationalisation of innovation, with a rise in acquisitions and partnerships with academia.

Report Download

You understand that your information will be used in accordance with our Privacy Policy, and that you may withdraw your permission to receive any of our communications at any time.